biosimilars

Amgen Fight Over Copies of Biotech Drugs Gets High Court Review
Bloomberg
Sat, 01/14/17 - 03:35 pm
Amgen
Supreme Court
Neupogen
Novartis
Sandoz
biosimilars
FDA issues long-awaited guidance on biosimilar naming
BioPharma Dive
Fri, 01/13/17 - 09:37 am
FDA
biosimilars
drug names
As biosimilars take root, threat grows for biologics makers
BioPharma Dive
Sun, 01/1/17 - 11:55 am
biosimilars
3 Biggest Risks for AbbVie in 2017
Motley Fool
Wed, 12/28/16 - 11:03 am
AbbVie
Humira
biosimilars
Imbruvica
Viekira Pak
Elagolix
risankizumab
Payers may see biosims as a no-brainer, but marketing them won't be
Fierce Pharma
Tue, 12/13/16 - 10:25 am
biosimilars
PBMs
drug ads
drug marketing
Report: Biosimilars, specialty drugs inversely impact drug spend
BioPharma Dive
Thu, 12/8/16 - 10:12 am
biosimilars
specialty medicines
drug spending
Amgen, Allergan Seek EU OK for Avastin Biosimilar
Investopedia
Mon, 12/5/16 - 09:59 am
Amgen
Allergan
Avastin
biosimilars
Europe
ABP 215
non-squamous lung cancer
As Humira readies for biosimilar rivals, AbbVie looks to ASH to build oncology momentum
Fierce Pharma
Sat, 12/3/16 - 09:21 am
Humira
AbbVie
biosimilars
ASH
Pfizer's Herceptin biosimilar succeeds in key breast cancer study
Yahoo/Reuters
Wed, 11/30/16 - 09:44 pm
Pfizer
biosimilars
Herceptin
PF-05280014
HER2-positive metastatic breast cancer
What Happened in Biotech in 2016?
Motley Fool
Tue, 11/22/16 - 09:57 pm
biotech
M&A
biosimilars
IPOs
Editas Medicine
CRISPR Therapeutics
Pfizer
Medivation
Celgene
Juno Therapeutics
Sarepta Therapeutics
Amgen, Allergan step up to challenge Roche's Avastin with FDA biosim filing
Fierce Pharma
Wed, 11/16/16 - 09:57 am
Amgen
Allergan
Roche
Avastin
biosimilars
FDA
ABP 215
AbbVie: Take That Coherus!
Barron's
Tue, 11/8/16 - 09:58 am
AbbVie
Coherus Biosciences
Humira
biosimilars
Doctors willing to prescribe biosimilars, survey shows
BioPharma Dive
Thu, 11/3/16 - 09:38 am
biosimilars
physicians
Could This Look-A-Like Drug Be Merck's Next Big Seller?
Motley Fool
Sat, 10/29/16 - 01:21 pm
MK-1293
Merck
diabetes
insulin
Lantus
biosimilars
FDA approval could be delayed for Sanofi Genzyme’s next blockbuster
Bizjournals.com
Fri, 10/28/16 - 10:19 am
FDA
Sanofi
Sanofi Genzyme
drug manufacturing
biosimilars
Humira
Sarilumab
Could Pfizer's at-risk Inflectra launch set a biosimilars precedent for Amgen, Novartis?
Fierce Pharma
Mon, 10/24/16 - 09:50 am
Pfizer
drug launches
biosimilars
Inflectra
Amgen
Novartis
AbbVie Is Under Duress With Fierce Competition
Seeking Alpha
Thu, 10/20/16 - 09:20 am
AbbVie
Humira
biosimilars
Amgen
Baxalta
Shire
J&J optimistic in spite of biosimilar threat
BioPharma Dive
Wed, 10/19/16 - 10:39 am
JNJ
biosimilars
Remicade
Pfizer
rheumatoid arthritis
Pfizer set to start shipping Remicade biosimilar next month
Yahoo/Reuters
Tue, 10/18/16 - 12:03 am
Pfizer
Remicade
biosimilars
Inflectra
JNJ
rheumatoid arthritis
Merck Launches Biosimilars Clarified, a New Online Educational Resource about Biosimilar Medicines for Patients and the Healthcare Community
Yahoo
Fri, 10/14/16 - 11:44 am
Merck
biosimilars
patients
patient education

Pages